RCAMU
NVAX icon

Rothschild & Co Asset Management US’s Novavax NVAX Stock Holding History

Rothschild & Co Asset Management US’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-39,753
Closed -$2.93M – 273
2022
Q1 		$2.93M Sell
39,753
-18,966
-32% -$1.69M 0.04% 227
2021
Q4 		$8.4M Sell
58,719
-1,804
-3% -$310K 0.1% 191
2021
Q3 		$12.5M Sell
60,523
-16,972
-22% -$3.74M 0.16% 157
2021
Q2 		$16.5M Sell
77,495
-14,460
-16% -$2.65M 0.2% 147
2021
Q1 		$16.7M Buy
+91,955
New +$18.3M 0.21% 142

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Rothschild & Co Asset Management US's NVAX Position: Q2 2022 in Review

Rothschild & Co Asset Management US sold out of Novavax (NVAX) in Q2 2022, closing a stake of 39,753 shares — an estimated $2.93M sold.

Rothschild & Co Asset Management US first reported a position in NVAX in Q1 2021 and held it in 5 quarters. The position peaked at $16.7M in Q1 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • Rothschild & Co Asset Management US reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 39,753 Novavax shares in Q2 2022, an estimated $2.93M.
  • Rothschild & Co Asset Management US first reported a position in Novavax in Q1 2021 and held it in 5 quarters.
  • Rothschild & Co Asset Management US's Novavax position peaked at $16.7M in Q1 2021.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Rothschild & Co Asset Management US's 13F filing for Q2 2022, filed 9 Aug 2022.